基于p53DNA的泽泻醇抗肿瘤分子机制研究
[1] Zhang L L, Xu Y L, Tang Z H, et al. Phytomedicine, 2016, 23(8): 800.
[2] Xu W, Li T, Qiu J F, et al. Anti-Cancer Agents in Medicinal Chemistry, 2015, 15(2): 228.
[3] Ma Q, Han L, Bi X, et al. Phytochemistry, 2016, 131: 150.
[4] Meek D W. Biochemical Journal, 2015, 469(3): 325.
[5] Liao J C C, Lam R, Brazda V, et al. Structure, 2011, 19(3): 418.
[6] Dehkordi M N, Bordbar A K, Lincoln P, et al. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2012, 90: 50.
[8] Shen H Y, Shao X L, Xu H, et al. International Journal of Electrochemical Science, 2011, 6: 532.
[9] Li F, Cao L, Li X, et al. Toxicology Letters, 2015, 232(2): 533.
[10] Ezhuthupurakkal P B, Polaki L R, Suyavaran A, et al. Materials Science and Engineering: C, 2017, 74: 597.
[11] Pakravan P, Masoudian S. Iranian Journal of Pharmaceutical Research: IJPR, 2015, 14(1): 111.
[12] Tarushi A, Polatoglou E, Kljun J, et al. Dalton Transactions, 2011, 40(37): 9461.
[13] Carr M I, Jones S N. Translational Cancer Research, 2016, 5(6): 707.
[14] XU Fei, CHEN Jun, GU Wei, et al(徐 飞, 陈 军, 谷 巍, 等). Chinese Journal of Pharmaceatical Analysis(药物分析杂志), 2011, 31(11): 2035.
[15] Xu Fei, Wu Qinan, Chen Jun, et al. Bioorganic & Medicinal Chemistry Letters, 2014, 24(17): 4099.
[16] XU Fei, ZHANG Lin-qun, HE Li-wei, et al(徐 飞, 张林群, 何立巍, 等). Acta Chimica Sinica(化学学报), 2011, 69(19): 2228.
[17] XU Fei, YU Hui, LU Cai, et al(徐 飞, 于 慧, 陆 彩, 等). Journal of Nanjing University of Traditional Chinese Medicine(南京中医药大学学报), 2016, (5): 451.
[18] XU Fei, LU Cai, WU Qi-nan, et al(徐 飞, 陆 彩, 吴启南, 等). Traditional Chinese Drug Research and Clinical Pharmacology(中药新药与临床药理), 2016, 27(6): 737.
[19] Xu Fei, Yu Hui, Lu Cai, et al. Evidence-Based Complementary and Alternative Medicine, 2016, 2016: 4753852.
陆彩, 于慧, 徐飞, 谷巍, 吴启南, 陈军. 基于p53DNA的泽泻醇抗肿瘤分子机制研究[J]. 光谱学与光谱分析, 2018, 38(12): 3683. LU Cai, YU Hui, XU Fei, GU Wei, WU Qi-nan, CHEN Jun. Study of Anti-Tumor Mechanism of Alisol Acetates Based on p53DNA[J]. Spectroscopy and Spectral Analysis, 2018, 38(12): 3683.